Sir, Pseudoexfoliation syndrome and cardiovascular disease: studies must control for all cardiovascular risk factors I read with interest the case-control study by Gonen et al 1 who sought to identify the incidence of renal artery stenosis (RAS) and abdominal aortic aneurysm (AAA) in patients with pseudoexfoliation syndrome (PXE).
PXE affects 30% of patients over 60 years of age; 1 not all can undergo ultrasonographic screening. Elucidating the quantitative contribution-or relative risk-of PXE to cardiovascular disease is critical in identifying patients at significant cardiovascular risk who can be referred from ophthalmic clinics for further management. Any study seeking to evaluate the significance of a candidate cardiovascular risk factor must therefore identify and control all other established cardiovascular risk factors (Table 1) .
Gonen et al 1 did not account for serum cholesterol and urinary albumin excretion-two major independent cardiovascular risk factors associated with AAA and RAS-which may have conceivably contributed to their development. These were not obviously examined as explicit parameters, nor proven statistically equivalent between PEX cases and controls.
Hypercholesterolaemia has been demonstrated as an independent risk factor for both RAS and AAA. Overall, 33% of patients with heterozygous familial hypercholesterolaemia have RAS on formal renal angiography, predominantly proximal in location. 2 Meta-analysis of pooled data from eight studies identified significantly lower HDL and higher LDL cholesterol in patients with AAA compared to controls. 3 Microalbuminuria (430 mg/24 h) is an independent cardiovascular risk factor and predictive of all-cause cardiovascular mortality (relative risk of 3.2). 4 Microalbuminuria is associated with increased renovascular resistance and reduced aortic compliance in diabetic subjects, after adjustment for other cardiovascular risk factors. 5 Microalbuminuria may conceivably influence renal artery peak systolic velocity parameters used as an end point in this study.
A prospective longitudinal cohort study is required in patients with PXE to determine the relative risk of serious cardiovascular events in relation to other risk factors. Alternatively, ocular examination of subjects in large existing population-based studies such as the Framingham Heart Study may help to identify the contribution of PXE to cardiovascular risk.
Urinary albumin estimation and serum cholesterol assays may have added further value to this study by excluding potentially confounding variables on the expressions of cardiovascular disease in PXE.
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Serum cholesterol levels were not investigated in this study. On the other hand, all subjects were examined about history of cardiovascular diseases and the patients with cardiovascular diseases were excluded from the study. Heterozygous familial hypercholesterolemia is among the most common inborn errors of metabolism and occurs in approximately one in 500 persons; affected individuals can usually be identified from birth by elevated levels of plasma LDL cholesterol. 3 Heterozygous familial hypercholesterolemia is accelerated vascular disease, especially coronary artery disease. 4 There was a significant association between total plasma cholesterol level and coronary artery disease incidence. 5 Although the exclusion of the serum cholesterol data might seem like a limiting factor of the study, we consider that vascular disease risk associated with hypercholesterolemia may be eliminated because of the patients with coronary artery disease were excluded from the study.
We also believe that a prospective longitudinal cohort study should be performed in patients with PEX to determine the relative risk of serious cardiovascular events in relation to other risk factors.
Eye ( 1 In 1999 Eke and colleagues 2 published the unexpected finding that following corneal abrasion with a fingernail, the use of topical lubricants increased the risk of
